GLP-1 Documentary Guide: What to Watch and What to Check (October 2026)

01 · The short answer

Is there a GLP-1 documentary worth watching?

Yes, several broadcasters and streamers have made films and current-affairs programmes about GLP-1 medicines, but which titles are on which service changes often. Availability depends on your country, your subscription and the month you search.

Treat forum chatter as a prompt to search, not as confirmation that a programme exists. If a streaming service does not list it, it is not there for you.

02 · What to expect

What these documentaries usually cover, and what they skip

Most GLP-1 documentaries centre on a few people's experiences and then zoom out to culture, food industry and diet history. That makes for compelling viewing. It also means the medical detail is often compressed or absent.

A good rule: if a programme names a dose, a timescale or a percentage, look up the same point in the product information or the trial paper before acting on it.

03 · Your next step

What to do after watching

If a documentary has made you wonder whether treatment could suit you, the next step is a conversation with a prescriber, not a purchase. Mounjaro is a prescription-only medicine, supplied only after an online consultation reviewed by a GPhC-registered prescriber, and it is used alongside a reduced-calorie diet and increased physical activity.¹ Individual results vary.

Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full. If you are curious about cost, the Mounjaro pen starts with a 2.5mg pen: your first 2.5mg pen costs £129.99 with code FIRST40 (standard price £169.99). Our weight loss clinic page explains the wider service.

Related guide: Mounjaro documentary.

04 · Finding a documentary

Where to watch a GLP-1 documentary in the UK

The most dependable way to find a GLP-1 documentary is to search each service yourself, because catalogues differ between countries and change without notice. A title that appears on a US streaming service may not be offered in the UK, and the reverse is also true. Listings on third-party websites often lag behind, so treat them as a starting point.

Begin with the free-to-view public broadcasters. BBC iPlayer carries current-affairs programmes and science documentaries for a limited time after broadcast, and Channel 4 and ITVX do the same. Searching for words such as weight loss jabs, Ozempic, Wegovy, Mounjaro or GLP-1 usually surfaces anything available. If a programme has expired, the broadcaster's page may still describe it, which helps you decide whether it is worth hunting down.

Next, check the paid streamers. Netflix, Disney+, Prime Video and Apple TV each have their own search, and Netflix lets you add a title to a list so you are notified when it arrives.

Documentary-style podcasts and interviews are easier to find and are often more detailed. A clinician talking at length about obesity treatment usually gives you more usable context than a short film built around personal stories. Podcast apps let you search the same keywords and filter by recent episodes.

Video platforms host talks, panel discussions and clips. Quality varies enormously. Look for content from clinicians, universities, charities or established broadcasters, and be cautious of anything where the presenter is also selling a product. A supplement seller who calls their product nature's Ozempic is marketing, not documenting; low-cost supplements carry no clinical oversight and are not the same as licensed medicines.

Finally, remember that a programme is a snapshot. Prescribing rules, NHS access and product information move on after filming. A documentary that looked current when it was made may describe a situation that has since changed.

Our related guide on GLP-1 technology is a helpful companion if a film leaves you with questions about how the medicines are made and delivered.

When you do find something worth watching, make a short note of any specific claim that surprises you. Afterwards, check it against the licensed product information or ask a prescriber. That small habit turns entertainment into useful preparation for a consultation.

05 · Judging claims on screen

How to judge medical claims in a documentary

Start by asking who is speaking and what they gain. A presenter with a product to sell, a clinic to promote or a book to launch is not an impartial source. Clinicians and researchers who disclose their funding and their limits are easier to trust, but even they are giving a view, not the licence for the medicine.

Second, separate three kinds of statement: personal experience, expert opinion and trial evidence. A person saying they felt less hungry is describing their own experience. A doctor saying the medicine has changed practice is giving an opinion. A trial result with a named study, a defined group of participants and a stated duration is evidence. Only the last kind supports a statement such as an average result, and even then trial averages do not predict your own result.

Third, watch for the language of certainty. Real medicine rarely promises specific results. If a film or an advert says a medicine will deliver a particular outcome for everyone, or quotes dramatic weight-loss claims in a short time, treat that as a warning. The licensed product information is written to describe how a medicine is used, what to watch for and who should not take it.

Fourth, check the dose and the product. Mounjaro (tirzepatide) is a once-weekly injection supplied as a pre-filled multi-dose pen in six strengths, 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg.¹

Fifth, look at the source of the medicine shown. Documentaries about online supply often show people buying from sellers with no consultation. A legitimate UK supplier is registered with the General Pharmaceutical Council. You can check ours, registration 9012878, on the GPhC public register. Anyone offering to supply a prescription medicine without a consultation or prescription should be avoided.

Sixth, read the patient information leaflet. It is the plain-language companion to the product information and covers how to use the pen, what side effects to look out for and when to seek help.¹³ Nothing in a documentary replaces it.

Seventh, be wary of before-and-after imagery. Photographs do not show diet, activity, other health conditions, dose history or how long treatment lasted. They also tend to show the best outcomes, not the typical ones.

Finally, notice what is missing. A film that dwells on the dramatic loss but never mentions side effects, medical review or the need for a reduced-calorie diet is telling only part of the story. Our related guide on GLP-1 physiology goes deeper on how these hormones work if you want to test what you have heard against the basics.

06 · What the science says

What the science behind GLP-1 medicines actually says

The core idea in most documentaries is correct: medicines that act on gut-hormone receptors change appetite signals. The detail matters, though, and it differs between products. Mounjaro is the brand name for tirzepatide, a once-weekly injectable prescription medicine made by Eli Lilly, licensed in the UK for weight management in adults and for type 2 diabetes.¹

Tirzepatide is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin. In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.¹ That dual action distinguishes Mounjaro from single-action GLP-1 medicines such as semaglutide, sold as Wegovy and Ozempic. Documentaries often use Ozempic as shorthand for the whole class, which blurs these differences.

Results come from trials, and the headline trial for tirzepatide in weight management is SURMOUNT-1. In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.²

These are trial averages. Individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.² A film that features someone with a striking outcome is showing the upper end, not the typical case.

To make the percentage tangible without projecting your own result: for someone starting at 100 kg, 20.9% is about 21 kg. That is straight arithmetic on a trial average and says nothing about how long it would take you or whether you would match it.

It is also worth knowing that trials of different medicines cannot be lined up side by side as if they were a race. Each trial recruited different people and ran for its own duration, so a documentary that sets one number against another is oversimplifying.

Keep the evidence in proportion. Trial participants were supported, monitored and encouraged to follow lifestyle advice. Real-world treatment through a prescriber, with monthly review and dose titration, aims to mirror that support, which is why we include ongoing clinical review for our patients. Our guide on Regeneron and GLP-1 shows how new entrants in this area are discussed without overstating what is known.

07 · Stopping and regain

Are people on GLP-1 for life, and why does weight return?

Many documentaries end on this question: what happens when treatment stops. Whether someone stays on treatment, reduces or stops is a decision made with their prescriber, based on their health, their goals and how they respond.

The mechanism helps explain why people talk about regain. Tirzepatide works by activating GIP and GLP-1 receptors, which help regulate appetite and slow how quickly the stomach empties.¹ Those effects are linked to the medicine being present. Tirzepatide has a half-life of about five days, so after a final dose it takes roughly 4–5 weeks to clear the system.¹ As it clears, the extra help with fullness and hunger fades. People who then find eating feels harder to manage can gain weight, particularly if the habits that supported their reduced-calorie diet have not become routine.

That is a reasonable reading of how the medicine works, not a prediction for any individual. Some people maintain well, some regain part of what they lost, and trial averages do not predict your own result. A documentary that shows only one outcome, dramatic regain or perfect maintenance, is leaving out the range.

Treatment is licensed for use alongside a reduced-calorie diet and increased physical activity.² The practical lesson is to use treatment time to build routines you can keep: how you plan meals, how you stay active, how you handle eating out and stress. Those habits are what you carry forward whichever way the medicine decision goes.

If you are thinking about stopping, talk to your prescriber first rather than simply letting pens run out. In SURMOUNT-4, people who stopped tirzepatide after 36 weeks regained on average 14% of body weight over the following year, while those who continued treatment lost a further 5.5% on average.¹⁴ Your prescriber can discuss whether to step down, whether to pause, and what to watch for afterwards. Our patients have ongoing monthly reviews, dose titration and follow-up assessments by the prescribing team, so there is a clinical conversation built in. Repeat orders re-check suitability and nothing auto-ships, so the choice to continue is always an active one.

Finally, resist anyone who describes the outcome as inevitable, whether they say you must stay on treatment forever or that you will definitely regain. Neither is a fair summary. The honest position is that it depends on you, your health and your plan, and a prescriber is the right person to help you weigh it up.

08 · NHS and private routes

NHS or private: how people actually get treatment

Documentaries often leave viewers unsure whether they can get these medicines on the NHS. The accurate picture is phased. Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).⁴⁶ Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.

If you want to explore the NHS route, start with your GP. They can tell you where your local area is in the rollout and whether you fall into a current group. The NHS also publishes a patient guide to the medicine that covers how it is used and what to expect.⁵ For Wegovy, NHS access runs through specialist weight-management services, so ask your GP about that too.

Private treatment is the alternative when the NHS route is not yet open to you or you prefer not to wait. The important thing is that it is regulated. A UK online pharmacy should be registered with the GPhC, should require a consultation and should have a prescriber review your answers. Our process is simple. A free online consultation is a short health questionnaire with no charge and no obligation. A GPhC-registered prescriber reviews it, not a scoring script. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full.

After approval, our registered pharmacy dispenses the order. Same-day dispatch applies when you order by 3pm, and delivery is free next-day tracked, in discreet temperature-controlled packaging. Saturday delivery costs £14.99. Genuine KwikPens come directly from Eli Lilly's UK distribution through official LillyDirect supply, and all six doses are in stock.

On cost: a first 2.5mg pen costs £129.99 with code FIRST40 (standard price £169.99). Later orders are £25 off the standard price with code DOSE25, and the discount for new customers applies at any dose, including if you are switching to us at a higher dose. Payment options include Visa, Mastercard, Klarna and pay-monthly plans, with no subscriptions. You can see current Mounjaro prices on the Mounjaro product page, and Wegovy details on the Wegovy pen page.

Neither route is morally superior. The NHS route costs nothing at the point of use beyond the standard prescription charge where it applies, and England's charge is £9.90 per item, though eligibility for these medicines is the bottleneck. Private treatment trades cost for speed and choice. What matters is that either way you are supervised by a clinician.

09 · Safety and counterfeits

Safety, side effects and avoiding fakes

The most serious risk a viewer takes after watching a documentary is buying from the wrong place. Counterfeit and unlicensed weight loss pens have been the subject of MHRA alerts, and the MHRA is the regulator to check for current warnings.⁷ A genuine supplier will be on the GPhC register, will ask you to complete a consultation, and will have a prescriber review it before anything is dispensed.

Warning signs are easy to list. A seller who offers to supply without a consultation or prescription is not operating lawfully. A price that looks too good to be true should make you stop, as should social media accounts that sell pens through direct messages, or products with no clear origin. Our pens are genuine KwikPens, sourced directly from Eli Lilly's UK distribution through official LillyDirect supply.

Mounjaro's side effects are mostly digestive: the most common, affecting more than 1 in 10 people, are nausea, diarrhoea, vomiting, constipation and abdominal discomfort, and they usually ease as your body adjusts. If you have any symptom you are unsure about, speak to your prescriber or pharmacist. If a symptom is not on the leaflet's list, it is not a listed side effect; tell your prescriber about any new or lasting symptom. Seek immediate medical help for severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of the skin or eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing.

You can also report suspected side effects yourself through the MHRA Yellow Card scheme, which is open to patients as well as healthcare professionals.¹⁹ Reporting helps regulators spot patterns. It is not a substitute for medical care when you are unwell.

Medicines can interact with each other. If you take other prescription medicines, particularly for diabetes, tell your prescriber so doses can be reviewed. This is part of why a genuine consultation asks about your whole health picture. Our prescribers also follow up through monthly reviews and dose titration, and repeat orders re-check suitability.

Mounjaro is not suitable for everyone. You should not take it if you are allergic to tirzepatide or any of its ingredients, and it should not be used during pregnancy or while trying to conceive. If you become pregnant during treatment, stop the medicine and tell your prescriber promptly. Your prescriber will take extra care, or may recommend against treatment, if you have a history of pancreatitis, severe gut or digestive disease, diabetic retinopathy, or gallbladder problems. Mounjaro is licensed for adults and used alongside a reduced-calorie diet and increased physical activity.¹ Unsuitable orders are refunded automatically in full. If a documentary leaves you worried about a particular risk, bring that worry to the consultation; it is the right place to ask.

Storage is another practical point that films skip. Keep unopened pens in the fridge at 2–8°C until first use, and they keep until the printed expiry date. Once in use, a KwikPen can be kept out of the fridge at a temperature not above 30°C for up to 30 days after first use, and must then be thrown away. Do not use a pen that has been above 30°C or has been frozen. For anything else, follow the patient information leaflet and ask the pharmacy.¹³ Our orders include needles, a sharps bin and injection guidance, so you are not left working it out from a video.

10 · Semaglutide and alternatives

Ozempic, Wegovy and Mounjaro: untangling the names

Documentaries tend to use Ozempic as a catch-all, which confuses viewers. The names refer to different products. Ozempic is semaglutide licensed for type 2 diabetes only, and prescribing it for weight loss is off-label; Wegovy is also semaglutide, a single-action GLP-1 medicine. Mounjaro is tirzepatide, which acts on both GIP and GLP-1 receptors.¹ If a programme says people are using Ozempic for weight loss, it may mean any of these, so check which product and which licence applies.

Wegovy is the semaglutide product licensed for weight management. The 2.4mg dose is the licensed maintenance dose for weight management. Mounjaro's titration also runs across strengths from 2.5mg up to 15mg, depending on the prescriber's plan and your response.

You might also hear about liraglutide, sold as Saxenda and in some other products. It is supplied at a concentration of 6mg per millilitre and is a daily injection, unlike the once-weekly Mounjaro and Wegovy.

Oral options are arriving too. Wegovy tablets and Foundayo, an orforglipron tablet, have their own product information, and prices for tablets are on the relevant product pages rather than here. No trial has compared Mounjaro directly with either tablet, so their results should not be set against each other as if head to head. A documentary that does so is simplifying.

The question viewers usually have is which is better, and no licensed medicine is better for everyone. Only a trial that compares two medicines directly can answer it, and for tirzepatide against semaglutide that trial is SURMOUNT-5.¹⁵ Beyond the trial headline, choice also depends on your health, tolerance, preference for a weekly or daily schedule, and availability, which is why a prescriber decision beats a television one. Our related reading on whether Semglee is a GLP-1 shows how products with similar-sounding names can be entirely different medicines.

One last name trap is supplements marketed as natural versions of these drugs. They are low-cost supplements with no clinical oversight and are not licensed medicines. They have no comparable trial evidence, and dosing is not standardised. A documentary that treats them as equivalent is misleading you.

If you are weighing options after watching, write down your questions on dose, schedule, cost and follow-up, and take them to the consultation. A good prescriber will welcome them.

11 · Using what you watched

Turning a documentary into a useful conversation

A documentary can be the start of a good decision if you use it well. The aim is to leave with better questions, not a ready-made answer. Before a consultation, jot down what struck you: a claim you want checked, a worry about side effects, a hope about results. Then ask the prescriber to address each.

Be ready to describe your health honestly. A genuine consultation covers your medical history, your current medicines and your goals. This is not box-ticking. It is how a prescriber decides whether treatment is suitable and which dose to start on. Mounjaro is supplied only after an online consultation reviewed by a GPhC-registered prescriber and is used alongside a reduced-calorie diet and increased physical activity.¹

Set realistic expectations. In SURMOUNT-1, people on tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.² Those are averages from a trial and individual results vary. Some people will do better, some worse, and the figures say nothing about timing for you.

Think about the plan, not just the pen. Starting at the lowest strength and stepping up is how treatment is normally structured, which is why a first 2.5mg pen is where most people begin. The full ladder runs from 2.5mg to 15mg, and a prescriber, not a documentary, decides how far to go.

Plan support too. Our patients have ongoing monthly reviews, side-effect support and access to the GLPTrackr companion app, a free tool for tracking a GLP-1 journey on iOS and Android. If you need help, our support team is available Monday to Friday, 9am to 5pm by email at support@everydaymeds.co.uk, through the account portal chat or by phone on 0333 207 0413.

Finally, remember you can decide not to go ahead. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full. If you decide treatment is not for you, or you want to wait for the NHS route, that is a perfectly reasonable outcome. The most useful thing a documentary can do is prompt a conversation with a trusted clinician.

12 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹